The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
Medtronic announced that the FDA has approved new labeling for the company’s Endurant stent graft system for use in the t ...
Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback